Literature DB >> 2646470

Prevalence of cytoplasmatic islet cell antibodies and insulin autoantibodies is increased in subjects with genetically defined high risk for insulin-dependent diabetes mellitus.

B Kuglin1, J Bertrams, C Linke, F A Gries, H Kolb.   

Abstract

The presence of cytoplasmatic islet cell antibodies (ICA) and IgG insulin autoantibodies (IgG-IAA) has been observed in the prediabetic state of type 1 (insulin-dependent) diabetes (IDDM). We therefore analyzed the prevalence of these markers in sera from 1117 healthy HLA-typed first-degree relatives (1 degree Rel) of IDDM patients. ICA was determined by indirect immunofluorescence on cryostat sections of human pancreas. For IgG-IAA measurement a competitive solid-phase ELISA was used. ICA were present in 3.5% of 1 degree Rel vs 0.4% of controls (P less than 0.025). The highest frequencies of ICA were found in individuals of IDDM multiplex families (7.7%) and HLA-DR1,3 (5.4%), -DR1,4 (5.8%), and -DR3,4 (6.7%) positive subjects. We therefore conclude that the prevalence of ICA is increased in 1 degree Rel with high genetic risk for diabetes. IgG-IAA occurred in 9.9% of 1 degree Rel vs 1.4% of controls (P less than 0.01). Like ICA, IgG-IAA were significantly increased in a group of subjects being positive for either HLA-DR1,3 -DR1,4, or -DR3,4 (16.5%, P less than 0.01). In multiplex families, however, prevalence of IgG-IAA was not increased. In contrast to ICA there was an additional influence of age and sex: IgG-IAA were found more often in siblings (mean age, 16.6 years; prevalence, 15.0%) than in parents (mean age, 44.1 years; prevalence, 8.3%) of IDDM patients (P less than 0.01). In brothers the prevalence of IgG-IAA is higher than in other 1 degree Rel. Only a weak association between ICA and IgG-IAA was observed in subjects (n = 810) tested for both antibodies.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2646470     DOI: 10.1007/bf01735654

Source DB:  PubMed          Journal:  Klin Wochenschr        ISSN: 0023-2173


  16 in total

1.  Progress toward standardization of cytoplasmic islet cell-antibody assay.

Authors:  H Gleichmann; G F Bottazzo
Journal:  Diabetes       Date:  1987-05       Impact factor: 9.461

2.  HLA-DR effects in a large German IDDM dataset.

Authors:  L L Field; C Fothergill-Payne; J Bertrams; M P Baur
Journal:  Genet Epidemiol Suppl       Date:  1986

3.  Islet-cell antibodies in diabetes mellitus with autoimmune polyendocrine deficiencies.

Authors:  G F Bottazzo; A Florin-Christensen; D Doniach
Journal:  Lancet       Date:  1974-11-30       Impact factor: 79.321

Review 4.  Type I diabetes mellitus. A chronic autoimmune disease.

Authors:  G S Eisenbarth
Journal:  N Engl J Med       Date:  1986-05-22       Impact factor: 91.245

Review 5.  Insulin autoantibodies: their role in the pathogenesis of IDDM.

Authors:  J P Palmer
Journal:  Diabetes Metab Rev       Date:  1987-10

6.  First-degree relatives of patients with type I diabetes mellitus. Islet-cell antibodies and abnormal insulin secretion.

Authors:  S Srikanta; O P Ganda; A Rabizadeh; J S Soeldner; G S Eisenbarth
Journal:  N Engl J Med       Date:  1985-08-22       Impact factor: 91.245

7.  Are insulin autoantibodies markers for insulin-dependent diabetes mellitus?

Authors:  M A Atkinson; N K Maclaren; W J Riley; W E Winter; D D Fisk; R P Spillar
Journal:  Diabetes       Date:  1986-08       Impact factor: 9.461

8.  HLA-D and -DR antigens in genetic analysis of insulin dependent diabetes mellitus.

Authors:  P Platz; B K Jakobsen; N Morling; L P Ryder; A Svejgaard; M Thomsen; M Christy; H Kromann; J Benn; J Nerup; A Green; M Hauge
Journal:  Diabetologia       Date:  1981-08       Impact factor: 10.122

9.  Evidence of IgG autoantibodies against human proinsulin in patients with IDDM before insulin treatment.

Authors:  B Kuglin; F A Gries; H Kolb
Journal:  Diabetes       Date:  1988-01       Impact factor: 9.461

10.  Pancreatic islet-cell antibody as a marker for asymptomatic and latent diabetes and prediabetes.

Authors:  W J Irvine; R S Gray; C J McCallum
Journal:  Lancet       Date:  1976-11-20       Impact factor: 79.321

View more
  3 in total

1.  No association between islet cell antibodies and Coxsackie B, mumps, rubella and cytomegalovirus antibodies in non-diabetic individuals aged 7-19 years.

Authors:  W A Scherbaum; W Hampl; P Muir; M Glück; J Seissler; H Egle; H Hauner; B O Boehm; E Heinze; J E Banatvala
Journal:  Diabetologia       Date:  1991-11       Impact factor: 10.122

2.  Autoantibodies to the islet antigen ICA69 occur in IDDM and in rheumatoid arthritis.

Authors:  S Martin; J Kardorf; B Schulte; E F Lampeter; F A Gries; I Melchers; R Wagner; J Bertrams; B O Roep; A Pfützner
Journal:  Diabetologia       Date:  1995-03       Impact factor: 10.122

3.  Proinsulin autoantibodies are more closely associated with type 1 (insulin-dependent) diabetes mellitus than insulin autoantibodies.

Authors:  K Böhmer; H Keilacker; B Kuglin; A Hübinger; J Bertrams; F A Gries; H Kolb
Journal:  Diabetologia       Date:  1991-11       Impact factor: 10.122

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.